Line 1,210: |
Line 1,210: |
| |SP (prior AE) | | |SP (prior AE) |
| |- | | |- |
− | |Follicular Lymphoma||Disease||Ruthann Pfau | + | |Follicular Lymphoma||Disease||Updating by Rachel Burnside; Ruthann Pfau |
− | | | + | |7/28/2024 |
| | | | | |
| |PENDING | | |PENDING |
Line 1,217: |
Line 1,217: |
| |SG | | |SG |
| | | | | |
− | |SP (prior AE) | + | |SP (prior AE); has prior content in old template but same name in 5th edition - Rachel working on this outside of production site with new template to replace production site page later) |
| |- | | |- |
| | Testicular Follicular Lymphoma|| ||to be deleted | | | Testicular Follicular Lymphoma|| ||to be deleted |
Line 1,235: |
Line 1,235: |
| |SG | | |SG |
| | | | | |
− | |SP (prior AE); 2021 template added | + | |SP (prior AE); 2021 template added (no prior content; name to 5th edition version of In Situ Follicular B-cell Neoplasm will be changed later but Rachel working on 5th edition content in this production site) |
| |- | | |- |
| | Duodenal-Type Follicular Lymphoma||Disease||Rachel Burnside | | | Duodenal-Type Follicular Lymphoma||Disease||Rachel Burnside |
Line 1,244: |
Line 1,244: |
| |SG | | |SG |
| | | | | |
− | |SP (prior AE); 2021 template added | + | |SP (prior AE); 2021 template added (name same in 5th edition version and no prior content; Rachel working on 5th edition content in this production site) |
| |- | | |- |
| |Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee) | | |Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee) |
Line 1,764: |
Line 1,764: |
| |SP (prior AE) | | |SP (prior AE) |
| |- | | |- |
− | | Angioimmunoblastic T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee) | + | | Angioimmunoblastic T-cell Lymphoma||Disease||Updating by Rachel Burnside; Ruthann Pfau, Sara Akhavanfard (trainee) |
− | | | + | |7/28/2023 |
| | | | | |
| |PENDING | | |PENDING |
Line 1,771: |
Line 1,771: |
| |SK | | |SK |
| | | | | |
− | |SP (prior AE) | + | |SP (prior AE); (has prior content and name will change in 5th edition - Rachel working on this outside of production site to be replaced later by Nodal TFH Cell Lymphoma, Angioimmunoblastic-Type) |
| |- | | |- |
− | | Follicular T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee) | + | | Follicular T-cell Lymphoma||Disease||Rachel Burnside |
− | | | + | |7/28/2023 |
| | | | | |
| |PENDING | | |PENDING |
Line 1,780: |
Line 1,780: |
| |SK | | |SK |
| | | | | |
− | |SP (prior AE) | + | |SP (prior AE); 2021 template added (name to 5th edition version of Nodal TFH Cell Lymphoma, Follicular-Type will be changed later but Rachel working on 5th edition content in this production site) |
| |- | | |- |
| | Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg | | | Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg |